• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Botox

Biotech

Allergan pays Exicure $25M to discover hair loss drugs

Exicure is set to receive $25 million upfront to apply its spherical nucleic acid technology to two collaborative programs. 
Nick Paul Taylor Nov 14, 2019 7:00am

Allergan defuses Botox threat with $195M Bonti buy

Sep 14, 2018 11:15am

Helmed by former Allergan execs, Bonti bags $15M

Jan 24, 2018 10:45am

Evolus plans $75M IPO to bring Botox biosimilar to market

Jan 10, 2018 5:36am

Revance’s rival to Allergan’s Botox aces phase 3

Dec 5, 2017 9:30am

Dodgy stem cell clinics; New CMO for Context—News of Note

Jul 19, 2017 10:08am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy